BCRX logo

BioCryst Pharmaceuticals, Inc. (BCRX) Gross Profit

Annual Gross Profit:

$436.98M+$111.89M(+34.42%)
December 31, 2024

Summary

  • As of today, BCRX annual gross profit is $436.98 million, with the most recent change of +$111.89 million (+34.42%) on December 31, 2024.
  • During the last 3 years, BCRX annual gross profit has risen by +$287.85 million (+193.02%).
  • BCRX annual gross profit is now at all-time high.

Performance

BCRX Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXincome statement metrics

Quarterly Gross Profit:

$160.23M+$19.59M(+13.93%)
June 30, 2025

Summary

  • As of today, BCRX quarterly gross profit is $160.23 million, with the most recent change of +$19.59 million (+13.93%) on June 30, 2025.
  • Over the past year, BCRX quarterly gross profit has increased by +$52.95 million (+49.36%).
  • BCRX quarterly gross profit is now at all-time high.

Performance

BCRX Quarterly Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXincome statement metrics

TTM Gross Profit:

$539.50M+$52.95M(+10.88%)
June 30, 2025

Summary

  • As of today, BCRX TTM gross profit is $539.50 million, with the most recent change of +$52.95 million (+10.88%) on June 30, 2025.
  • Over the past year, BCRX TTM gross profit has increased by +$164.63 million (+43.92%).
  • BCRX TTM gross profit is now at all-time high.

Performance

BCRX TTM Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXincome statement metrics

Gross Profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

BCRX Gross Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+34.4%+49.4%+43.9%
3Y3 Years+193.0%+146.7%+168.4%
5Y5 Years+876.8%+100.0%+1066.1%

BCRX Gross Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+193.0%at high+137.6%at high+131.8%
5Y5-Yearat high+2608.1%at high+4167.0%at high+4092.9%
All-TimeAll-Timeat high>+9999.0%at high+1631.8%at high+1524.3%

BCRX Gross Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$160.23M(+13.9%)
$539.50M(+10.9%)
Mar 2025
-
$140.63M(+12.4%)
$486.55M(+11.3%)
Dec 2024
$436.98M(+34.4%)
$125.09M(+10.2%)
$436.98M(+8.4%)
Sep 2024
-
$113.55M(+5.8%)
$403.23M(+7.6%)
Jun 2024
-
$107.28M(+17.8%)
$374.87M(+7.5%)
Mar 2024
-
$91.06M(-0.3%)
$348.72M(+7.3%)
Dec 2023
$325.10M(+23.7%)
$91.34M(+7.2%)
$325.10M(+4.7%)
Sep 2023
-
$85.19M(+5.0%)
$310.41M(+4.5%)
Jun 2023
-
$81.13M(+20.3%)
$297.05M(+5.8%)
Mar 2023
-
$67.44M(-12.0%)
$280.86M(+6.9%)
Dec 2022
$262.80M(+76.2%)
$76.65M(+6.7%)
$262.80M(+12.9%)
Sep 2022
-
$71.83M(+10.6%)
$232.71M(+15.8%)
Jun 2022
-
$64.95M(+31.6%)
$201.04M(+8.4%)
Mar 2022
-
$49.37M(+6.0%)
$185.50M(+24.4%)
Dec 2021
$149.13M(+824.2%)
$46.57M(+16.0%)
$149.13M(+40.3%)
Sep 2021
-
$40.15M(-18.8%)
$106.32M(+50.3%)
Jun 2021
-
$49.42M(+280.3%)
$70.74M(+231.7%)
Mar 2021
-
$12.99M(+246.0%)
$21.32M(+65.7%)
Dec 2020
$16.14M(-63.9%)
$3.75M(-17.9%)
$12.87M(-72.2%)
Sep 2020
-
$4.58M(>+9900.0%)
$46.27M(+6.9%)
Jun 2020
-
$0.00(-100.0%)
$43.27M(-2.8%)
Mar 2020
-
$4.54M(-87.8%)
$44.51M(+0.3%)
Dec 2019
$44.73M(+126.0%)
$37.15M(+2259.0%)
$44.37M(+355.4%)
Sep 2019
-
$1.57M(+26.9%)
$9.74M(+3.5%)
Jun 2019
-
$1.24M(-71.8%)
$9.41M(-53.9%)
Mar 2019
-
$4.40M(+74.2%)
$20.42M(+3.3%)
Dec 2018
$19.80M(-15.7%)
$2.53M(+103.6%)
$19.76M(-5.5%)
Sep 2018
-
$1.24M(-89.9%)
$20.91M(-23.1%)
Jun 2018
-
$12.25M(+227.3%)
$27.17M(+52.4%)
Mar 2018
-
$3.74M(+2.0%)
$17.82M(-23.3%)
Dec 2017
$23.48M(-0.7%)
$3.67M(-51.1%)
$23.22M(-11.0%)
Sep 2017
-
$7.50M(+158.3%)
$26.08M(-0.1%)
Jun 2017
-
$2.90M(-68.2%)
$26.11M(-6.3%)
Mar 2017
-
$9.14M(+40.0%)
$27.88M(+18.7%)
Dec 2016
$23.65M(-49.0%)
$6.53M(-13.3%)
$23.48M(+9.2%)
Sep 2016
-
$7.53M(+61.3%)
$21.50M(-8.9%)
Jun 2016
-
$4.67M(-1.5%)
$23.60M(-46.8%)
Mar 2016
-
$4.74M(+4.2%)
$44.33M(-4.3%)
Dec 2015
$46.36M(+246.0%)
$4.55M(-52.8%)
$46.34M(-1.8%)
Sep 2015
-
$9.64M(-62.1%)
$47.19M(+15.8%)
Jun 2015
-
$25.40M(+276.2%)
$40.75M(+143.0%)
Mar 2015
-
$6.75M(+25.0%)
$16.77M(+25.1%)
Dec 2014
$13.40M(-20.9%)
$5.40M(+68.9%)
$13.40M(-27.5%)
Sep 2014
-
$3.20M(+125.7%)
$18.49M(+5.0%)
Jun 2014
-
$1.42M(-58.1%)
$17.62M(+4.1%)
Mar 2014
-
$3.38M(-67.7%)
$16.93M(+0.0%)
Dec 2013
$16.93M(-33.7%)
$10.49M(+351.3%)
$16.93M(+63.5%)
Sep 2013
-
$2.33M(+218.1%)
$10.35M(-23.5%)
Jun 2013
-
$731.00K(-78.4%)
$13.54M(+5.7%)
Mar 2013
-
$3.38M(-13.7%)
$12.81M(+35.9%)
Dec 2012
$25.53M(+36.1%)
$3.92M(-28.9%)
$9.43M(+310.6%)
Sep 2012
-
$5.51M(>+9900.0%)
-$4.48M(+77.3%)
Jun 2012
-
$0.00(0.0%)
-$19.70M(+34.7%)
Mar 2012
-
$0.00(+100.0%)
-$30.16M(+20.4%)
Dec 2011
$18.76M(-68.8%)
-$9.99M(-2.9%)
-$37.88M(-236.8%)
Sep 2011
-
-$9.71M(+7.2%)
-$11.25M(-210.8%)
Jun 2011
-
-$10.46M(-35.5%)
$10.15M(-63.5%)
Mar 2011
-
-$7.72M(-146.4%)
$27.83M(-54.5%)
Dec 2010
$60.03M(-14.3%)
$16.64M(+42.4%)
$61.15M(-35.3%)
Sep 2010
-
$11.69M(+62.0%)
$94.46M(+14.1%)
Jun 2010
-
$7.22M(-71.8%)
$82.77M(+9.6%)
Mar 2010
-
$25.59M(-48.8%)
$75.55M(+40.2%)
Dec 2009
$70.05M
$49.96M(>+9900.0%)
$53.90M(+1265.0%)
DateAnnualQuarterlyTTM
Sep 2009
-
$0.00(0.0%)
$3.95M(0.0%)
Jun 2009
-
$0.00(-100.0%)
$3.95M(0.0%)
Mar 2009
-
$3.95M(>+9900.0%)
$3.95M(-62.0%)
Dec 2008
$54.94M(-21.4%)
$0.00(0.0%)
$10.40M(0.0%)
Sep 2008
-
$0.00(0.0%)
$10.40M(0.0%)
Jun 2008
-
$0.00(-100.0%)
$10.40M(0.0%)
Mar 2008
-
$10.40M(>+9900.0%)
$10.40M(>+9900.0%)
Dec 2007
$69.87M(+1196.1%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2007
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2007
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2007
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2006
$5.39M(+856.4%)
$0.00(0.0%)
$566.00K(0.0%)
Sep 2006
-
$0.00(0.0%)
$566.00K(0.0%)
Jun 2006
-
$0.00(-100.0%)
$566.00K(0.0%)
Mar 2006
-
$566.00K(>+9900.0%)
$566.00K(+409.3%)
Dec 2005
-$712.70K(-12.7%)
$0.00(0.0%)
-$183.00K(0.0%)
Sep 2005
-
$0.00(0.0%)
-$183.00K(0.0%)
Jun 2005
-
$0.00(+100.0%)
-$183.00K(0.0%)
Mar 2005
-
-$183.00K(>-9900.0%)
-$183.00K(+25.0%)
Dec 2004
-$632.50K(>-9900.0%)
$0.00(0.0%)
-$244.00K(-250.6%)
Sep 2004
-
$0.00(0.0%)
$162.00K(+274.2%)
Jun 2004
-
$0.00(+100.0%)
-$93.00K(+76.0%)
Mar 2004
-
-$244.00K(-160.1%)
-$387.00K(+13.4%)
Dec 2003
$0.00(0.0%)
$406.00K(+259.2%)
-$447.00K(+61.4%)
Sep 2003
-
-$255.00K(+13.3%)
-$1.16M(+4.5%)
Jun 2003
-
-$294.00K(+3.3%)
-$1.21M(+3.9%)
Mar 2003
-
-$304.00K(+0.7%)
-$1.26M(-1.4%)
Dec 2002
$0.00(0.0%)
-$306.00K(+1.3%)
-$1.25M(-32.6%)
Sep 2002
-
-$310.00K(+9.6%)
-$940.00K(-49.2%)
Jun 2002
-
-$343.00K(-19.5%)
-$630.00K(-119.5%)
Mar 2002
-
-$287.00K(>-9900.0%)
-$287.00K(-117.4%)
Dec 2001
$0.00(0.0%)
$0.00(0.0%)
$1.65M(0.0%)
Sep 2001
-
$0.00(0.0%)
$1.65M(0.0%)
Jun 2001
-
$0.00(-100.0%)
$1.65M(0.0%)
Mar 2001
-
$1.65M(>+9900.0%)
$1.65M(-58.6%)
Dec 2000
$0.00(0.0%)
$0.00(0.0%)
$3.99M(0.0%)
Sep 2000
-
$0.00(0.0%)
$3.99M(0.0%)
Jun 2000
-
$0.00(-100.0%)
$3.99M(0.0%)
Mar 2000
-
$3.99M(>+9900.0%)
$3.99M(+4248.1%)
Dec 1999
$0.00(0.0%)
$0.00(0.0%)
$91.80K(0.0%)
Sep 1999
-
$0.00(0.0%)
$91.80K(-98.5%)
Jun 1999
-
$0.00(-100.0%)
$6.24M(-2.2%)
Mar 1999
-
$91.80K(>+9900.0%)
$6.38M(-2.2%)
Dec 1998
$0.00(0.0%)
$0.00(-100.0%)
$6.52M(-1.5%)
Sep 1998
-
$6.15M(+4290.7%)
$6.62M(+756.8%)
Jun 1998
-
$140.00K(-39.8%)
$772.60K(-57.8%)
Mar 1998
-
$232.60K(+132.6%)
$1.83M(+266.6%)
Dec 1997
$0.00(0.0%)
$100.00K(-66.7%)
-$1.10M(+35.3%)
Sep 1997
-
$300.00K(-75.0%)
-$1.70M(-6.3%)
Jun 1997
-
$1.20M(+144.4%)
-$1.60M(-77.8%)
Mar 1997
-
-$2.70M(-440.0%)
-$900.00K(-145.0%)
Dec 1996
$0.00(0.0%)
-$500.00K(-225.0%)
$2.00M(+146.5%)
Sep 1996
-
$400.00K(-78.9%)
-$4.30M(+4.4%)
Jun 1996
-
$1.90M(+850.0%)
-$4.50M(+27.4%)
Mar 1996
-
$200.00K(+102.9%)
-$6.20M(-3.3%)
Dec 1995
$0.00(0.0%)
-$6.80M(-3500.0%)
-$6.00M(-900.0%)
Sep 1995
-
$200.00K(0.0%)
-$600.00K(+68.4%)
Jun 1995
-
$200.00K(-50.0%)
-$1.90M(+40.6%)
Mar 1995
-
$400.00K(+128.6%)
-$3.20M(+27.3%)
Dec 1994
$0.00
-$1.40M(-27.3%)
-$4.40M(-46.7%)
Sep 1994
-
-$1.10M(0.0%)
-$3.00M(-57.9%)
Jun 1994
-
-$1.10M(-37.5%)
-$1.90M(-137.5%)
Mar 1994
-
-$800.00K
-$800.00K

FAQ

  • What is BioCryst Pharmaceuticals, Inc. annual gross profit?
  • What is the all-time high annual gross profit for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. annual gross profit year-on-year change?
  • What is BioCryst Pharmaceuticals, Inc. quarterly gross profit?
  • What is the all-time high quarterly gross profit for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. quarterly gross profit year-on-year change?
  • What is BioCryst Pharmaceuticals, Inc. TTM gross profit?
  • What is the all-time high TTM gross profit for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. TTM gross profit year-on-year change?

What is BioCryst Pharmaceuticals, Inc. annual gross profit?

The current annual gross profit of BCRX is $436.98M

What is the all-time high annual gross profit for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high annual gross profit is $436.98M

What is BioCryst Pharmaceuticals, Inc. annual gross profit year-on-year change?

Over the past year, BCRX annual gross profit has changed by +$111.89M (+34.42%)

What is BioCryst Pharmaceuticals, Inc. quarterly gross profit?

The current quarterly gross profit of BCRX is $160.23M

What is the all-time high quarterly gross profit for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high quarterly gross profit is $160.23M

What is BioCryst Pharmaceuticals, Inc. quarterly gross profit year-on-year change?

Over the past year, BCRX quarterly gross profit has changed by +$52.95M (+49.36%)

What is BioCryst Pharmaceuticals, Inc. TTM gross profit?

The current TTM gross profit of BCRX is $539.50M

What is the all-time high TTM gross profit for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high TTM gross profit is $539.50M

What is BioCryst Pharmaceuticals, Inc. TTM gross profit year-on-year change?

Over the past year, BCRX TTM gross profit has changed by +$164.63M (+43.92%)
On this page